Dr. Garcia-Puche Grant
Dr. Garcia-Puche Grant
The Dr. Garcia-Puche Grant for Innovation in Liquid Biopsy aims to recognize and support the most outstanding ideas and projects that revolutionize the detection and analysis of diseases through non-invasive biopsies. Geared towards researchers, entrepreneurs, and scientific teams, this grant encourages the development of technologies that enable faster, more accurate, and less intrusive diagnostics.
Participants will have the opportunity to present their proposals to the International Society for Liquid Biopsy (ISLB) through the committee in a public and competitive contest composed of International Experts in LB.
The grant carries a prize of 25,000 USD to support the recipient’s ongoing research endeavors.
Specific Objectives
Promote Innovation in Analysis
Encourage the creation and application of advanced methodologies in liquid biopsy, covering all its aspects from sample collection to the analysis of analytes. We seek projects that bring new perspectives and deepen our understanding of biomarkers in bodily fluids and their relation to various diseases.ground, objectives, and future plan. References should be attached separately.
Promote Multidisciplinary Research
Incentivize projects that integrate basic and clinical research to develop more effective diagnostic and therapeutic tools. This collaborative approach should aim to translate scientific findings into practical applications that improve disease management and prognosis.
Expand Knowledge of Analytes in Liquid Biopsy
Support studies that investigate how various analytes detected in liquid biopsies (such as circulating tumor cells, DNA, RNA, exosomes, and other biomarkers) contribute to the development and progression of diseases. This objective aims to foster a deeper understanding of the disease-biomarker dynamics and its impact on improving diagnostic and treatment protocols.
Increase Clinical Applicability of Liquid Biopsy
Motivate research oriented towards the direct clinical application of the results, so that advances in liquid biopsy can be quickly implemented in medical settings, thus improving early detection and monitoring of diseases through minimally invasive procedures.
These specific objectives are designed to attract proposals that not only advance the science behind liquid biopsy but also bring these advancements to clinical practice, thereby benefiting patients worldwide.
Evaluation Criteria
Originality and Innovation (25%)
Does the proposal introduce a new idea, approach, or technology?
Does it break away from conventional methods or significantly improve existing ones?
Social, Scientific, or Technological Impact (25%)
What level of change or benefit has it generated or is expected to generate?
Is the impact local, regional, or global?
Who benefits from it, and in what way?
Feasibility and Sustainability (15%)
Is the innovation realistically implementable or scalable?
Has long-term sustainability or adaptability been considered?
Quality of Project Presentation (10%)
Is the project summary well-written and structured?
Are the objectives, methodology, and results clearly communicated?
Applicant's Background and Experience (10%)
Does the candidate have relevant experience or education?
Does their profile reflect a commitment to innovation?
External Recognition and Validation (10%)
Has the work received awards, mentions, publications, or patents?
Are there letters of recommendation or valuable references included?
Ethics and Responsibility (5%)
Does the proposal adhere to ethical, legal, and sustainability standards?
Has the applicant declared the authenticity of the information provided?
2025 Application Open
The deadline for submissions has been extended to October 13.
Inquiries
For any question, please contact: [email protected]
Dr. José Luis García Puche (Granada, 1947–2022) was a leading figure in Spanish oncology and a pioneer in the modernization of cancer treatment in Andalusia. After earning his medical degree and PhD from the University of Granada, he continued his training at the Istituto Nazionale dei Tumori in Milan, one of Europe’s foremost cancer centers.
He devoted his entire professional career to the Hospital Clínico San Cecilio in Granada, where he founded and directed the Oncology Unit, establishing it as a center of excellence that integrated patient care, research, and teaching.
With tireless dedication, he advanced comprehensive care for cancer patients, promoted the development of palliative medicine, and introduced innovative therapies at a time when resources were scarce.
In the final stage of his career, together with Dr. María José Serrano, he founded the International Society of Liquid Biopsy (ISLB), headquartered in Granada, positioning the city as a global reference point for this groundbreaking technique, essential for early cancer diagnosis and disease monitoring.
His scientific, academic, and human legacy made him a highly respected and beloved physician, whose work continues to inspire the oncology community.
ISLB
ACTIVITIES
CONTACTS
Dr. Oloriz, 16 Street
CP 18012 Granada - Spain
+1 604 681 2153
(when asked for extension please enter: 164)
We’re also on Bluesky!
© 2022 - ISLB | designed & powered by publics iCC